References
- Andreassen C N. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncologica 2005; 44: 801–815
- Andreassen C N, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J, Yarnold J. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiotherapy and Oncology 2005; 75: 18–21
- Clarke D J, Northey C G, Mack L A, McNae I W, Alexeev D, Sawyer L, Campopiano D J. Cloning, expression, purification, crystallization and preliminary X-ray characterization of the full-length single-stranded DNA-binding protein from the hyperthermophilic bacterium Aquifex aeolicus. Acta Crystallographica. Section D, Biological Crystallography 2004; 60: 2009–2012
- Filippi A R, Franco P, Ricardi U. Is clinical radiosensitivity a complex genetically controlled event?. Tumori 2006; 92: 87–91
- Haley C S, Knott S A. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 1992; 69: 315–324
- Hofstetter J R, Trofatter J A, Kernek K L, Nurnberger J I, Mayeda A R. New quantitative trait loci for the genetic variance in circadian period of locomotor activity between inbred strains of mice. Journal of Biological Rhythms 2003; 18: 450–462
- Manly K F, Cudmore R H, Jr, Meer J M. Map Manager QTX, cross-platform software for genetic mapping. Mammalian Genome 2001; 12: 930–932
- Rogers P B, Plowman P N, Harris S J, Arlett C F. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiotherapy and Oncology 2000; 57: 143–154
- Safwat A, Bentzen S M, Turesson I, Hendry J H. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. International Journal of Radiation Oncology, Biology, Physics 2002; 52: 198–204
- Shibata M A, Horiguchi T, Morimoto J, Otsuki Y. Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer. The Journal of Gene Medicine 2003; 5: 219–231
- Simon M, Voss D, Park-Simon T W, Mahlberg R, Koster G. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas. Oncology reports 2006; 16: 127–132
- Tai I T, Dai M, Owen D A, Chen L B. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy. The Journal of Clinical Investigation 2005; 115: 1492–1502
- Weil M M, Stephens L C, Amos C I, Ruifrok A C, Mason K A. Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis. International Journal of Radiation Biology 1996; 70: 579–585
- Weil M M, Xia C, Xia X, Gu X, Amos C I, Mason K A. A chromosome 15 quantitative trait locus controls levels of radiation-induced jejunal crypt cell apoptosis in mice. Genomics 2001; 72: 73–77
- Williams J, Chen Y, Rubin P, Finkelstein J, Okunieff P. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Seminars in Radiation Oncology 2003; 13: 182–188
- Withers H R. Radiation biology and treatment options in radiation oncology. Cancer Research 1999; 59: 1676–1684
- Yang H, Yang K, Khafagi A, Tang Y, Carey T E, Opipari A W, Lieberman R, Oeth P A, Lancaster W, Klinger H P, Kaseb A O, Metwally A, Khaled H, Kurnit D M. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 7683–7688